Trader consensus on Polymarket reflects a 94.3% implied probability for "No" on a new coronavirus pandemic in 2026, driven by the absence of any World Health Organization declaration of a novel coronavirus outbreak—distinct from SARS-CoV-2 evolutions—through April 30. Official WHO Disease Outbreak News reports no such events in the past 30 days, with recent bulletins limited to measles in Bangladesh and avian influenza in Italy, while CDC data shows SARS-CoV-2 infections declining or stable in nearly all U.S. states as of April 21, alongside global test positivity below 2%. Enhanced surveillance via networks like CoViNet has detected no zoonotic spillovers of betacoronaviruses akin to SARS or MERS. This aligns with COVID-19's endemic transition, marked by a recent WHO simulation on April 27 emphasizing preparedness amid low transmission. Realistic challenges include an undetected animal reservoir spillover triggering rapid human-to-human spread before year-end, prompting a WHO pandemic alert, though historical rarity and proactive monitoring temper such risks.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNew Coronavirus Pandemic in 2026?
New Coronavirus Pandemic in 2026?
$11,900 Vol.
$11,900 Vol.
$11,900 Vol.
$11,900 Vol.
The resolution source will be official announcements from the World Health Organization.
Market Opened: Jan 6, 2026, 2:40 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects a 94.3% implied probability for "No" on a new coronavirus pandemic in 2026, driven by the absence of any World Health Organization declaration of a novel coronavirus outbreak—distinct from SARS-CoV-2 evolutions—through April 30. Official WHO Disease Outbreak News reports no such events in the past 30 days, with recent bulletins limited to measles in Bangladesh and avian influenza in Italy, while CDC data shows SARS-CoV-2 infections declining or stable in nearly all U.S. states as of April 21, alongside global test positivity below 2%. Enhanced surveillance via networks like CoViNet has detected no zoonotic spillovers of betacoronaviruses akin to SARS or MERS. This aligns with COVID-19's endemic transition, marked by a recent WHO simulation on April 27 emphasizing preparedness amid low transmission. Realistic challenges include an undetected animal reservoir spillover triggering rapid human-to-human spread before year-end, prompting a WHO pandemic alert, though historical rarity and proactive monitoring temper such risks.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions